Trial Profile
Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Apr 2021
Price :
$35
*
At a glance
- Drugs B cell lymphoma vaccine (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- Sponsors XEME Biopharma
- 07 Apr 2021 Planned End Date changed from 1 Jan 2023 to 1 Jun 2026.
- 07 Apr 2021 Planned primary completion date changed from 1 Jan 2022 to 1 Jun 2024.
- 07 Apr 2021 Planned initiation date changed from 1 Jan 2020 to 1 Jul 2021.